KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Current Deferred Revenue (2017 - 2025)

Globus Medical's Current Deferred Revenue history spans 9 years, with the latest figure at $27.7 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 13.03% year-over-year to $27.7 million; the TTM value through Dec 2025 reached $27.7 million, down 13.03%, while the annual FY2025 figure was $27.7 million, 13.03% down from the prior year.
  • Current Deferred Revenue reached $27.7 million in Q4 2025 per GMED's latest filing, up from $18.3 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $31.8 million in Q4 2024 to a low of $8.7 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $16.6 million, with a median of $16.0 million recorded in 2023.
  • Peak YoY movement for Current Deferred Revenue: skyrocketed 73.12% in 2024, then dropped 13.03% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $12.0 million in 2021, then increased by 17.26% to $14.1 million in 2022, then soared by 30.28% to $18.4 million in 2023, then surged by 73.12% to $31.8 million in 2024, then fell by 13.03% to $27.7 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Current Deferred Revenue are $27.7 million (Q4 2025), $18.3 million (Q3 2025), and $24.0 million (Q2 2025).